stock
EBS · Emergent BioSolutions Inc.
What Emergent BioSolutions Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live EBS price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on EBS.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 51,273,336 as of 2026-07-30 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -8.6%
- Net
- -23.0%
Returns
- ROE
- -51.8%
- ROA
- -15.8%
Health
- Current ratio
- 5.4x
- Debt/equity
- 1.7x
Deep value
- NCAV
- -$109.40M
- NCAV per share
- -$2.13
- Price/NCAV
- Locked
- NNWC
- -$341.40M
- NNWC per share
- -$6.66
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $234.30M | — | -$125.10M | -$180.20M | 10-Q filed 2026-08-06 |
| 2026-03-31 | $156.10M | — | $10.50M | $6.80M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $148.70M | — | -$27.90M | -$54.60M | 10-K filed 2026-02-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $231.10M | — | $76.50M | $51.20M | 10-Q filed 2025-10-30 |
| 2025-06-30 | $140.90M | — | $1.60M | -$12.00M | 10-Q filed 2026-08-06 |
| 2025-03-31 | $222.20M | — | $49.90M | $68.00M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $194.70M | — | -$9.50M | -$31.30M | 10-K filed 2026-02-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $293.80M | $161.20M | $64.50M | $114.80M | 10-Q filed 2025-10-30 Assembled from more than one filing; the filing above is only the newest of them. |
- Assets
- $1.12B
- Equity
- $341.40M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $742.90M | $100.10M | $52.60M | $156.80M |
| 2024-12-31 | $1.04B | -$108.70M | -$190.60M | $35.80M |
| 2023-12-31 | $1.05B | -$726.40M | -$760.50M | -$257.90M |
| 2022-12-31 | $1.12B | -$170.00M | -$211.60M | -$149.90M |
| 2021-12-31 | $1.77B | $341.40M | $219.50M | $96.10M |
| 2020-12-31 | $1.56B | $438.50M | $305.80M | $395.00M |
| 2019-12-31 | $1.11B | $114.10M | $54.50M | $101.10M |
| 2018-12-31 | $782.40M | $89.80M | $62.70M | -$30.30M |
| 2017-12-31 | $560.90M | $124.30M | $82.60M | $153.30M |
| 2016-12-31 | $488.80M | $105.50M | $51.80M | -$21.60M |
Company filings
events
Regulation FD disclosure
Regulation FD disclosureSep 148-KOther event
Other eventSep 18-KResults, Exit or restructuring costs, Executive or director change, Regulation FD disclosure
ResultsExit or restructuring costsExecutive or director changeRegulation FD disclosureAug 58-KMaterial agreement, Regulation FD disclosure
Material agreementRegulation FD disclosureJun 298-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureApr 308-KShareholder vote results
Shareholder vote resultsApr 308-K
5% owners ()
American Century ETF Trust
Passive stake
Vanguard Capital Management
Stake update
BlackRock, Inc.
Stake update
Vanguard Capital Management
Passive stake
Dimensional Fund Advisors LP
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Williams Paul Anthony
SVP, Products Business
Sale$19,590Oct 5, 9:16 AM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named EBS, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about EBS.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on EBS come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the EBS board